Exploration on the safety assessment of nanomaterials in China | Zendy

Xinli Shi | Zendy; Qiangbin Wang | Zendy; Kun Hu | Zendy; Xiumei Wang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Exploration on the safety assessment of nanomaterials in China

Author(s) -

Xinli Shi,

Qiangbin Wang,

Kun Hu,

Xiumei Wang

Publication year - 2012

Publication title -

interface focus

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.1

H-Index - 49

eISSN - 2042-8901

pISSN - 2042-8898

DOI - 10.1098/rsfs.2012.0017

Subject(s) - biomedicine , china , food and drug administration , nanotechnology , risk analysis (engineering) , engineering ethics , engineering , business , materials science , political science , bioinformatics , law , biology

More and more applications of nanomaterials have been achieved in the biomedicine field. Numerous nanomedical devices, such as bone grafts with nano-hydroxyapatite and the silver-based anti-bacteria products, have been developed and have been trying to enter into the Chinese market. The State Food and Drug Administration of China (SFDA) is facing a critical challenge of how to explore and supervise the safety assessment of the nanomedical products. This paper briefly introduces the approval status of nanomedical products and the current advances of the safety assessment of nanomaterials in China.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research